Abbott Laboratories (ABT) volatility increases into Q3 and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- US stock futures up as chip shares recover, oil prices decline
- Oil falls after OPEC+ agrees to raise output targets
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Abbott (ABT) Tops Q3 EPS by 1c; Narrows, Boosts FY16 EPS Outlook
October 19, 2016 7:46 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.29 billion.
GUIDANCE:
Abbott sees FY2016 EPS of $2.19 - $2.21, versus prior guidance of $2.14 - $2.24 and... More
